Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(46 sites)
United States
City of Hope National Medical Center, Duarte, California Tampa General Hospital, Tampa, Florida Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh, Pennsylvania Md Anderson Cancer Center, Houston, Texas Medical College of Wisconsin, Milwaukee, Wisconsin Australia
Concord Repatriation General Hospital, Concord, New South Wales St George Hospital, Kogarah, New South Wales Orange Health Hospital, Orange, New South Wales Gold Coast University Hospital, Southport, Queensland Monash Health, Clayton, Victoria St Vincents Hospital Melbourne, Fitzroy, Victoria Austin Health, Heidelberg, Victoria The Alfred Hospital, Melbourne, Victoria Fiona Stanley Hospital, Murdoch, Western Australia Linear Clinical Research, Nedlands, Western Australia One Clinical Research, Nedlands, Western Australia China
Peking University Peoples Hospital, Beijing, Beijing Municipality The First Hospital of Lanzhou University, Lanzhou, Gansu Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong The Second Peoples Hospital of Shenzhen, Shenzhen, Guangdong Henan Cancer Hospital, Zhengzhou, Henan Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi West China Hospital, Sichuan University, Chengdu, Sichuan Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang France
Hopital Claude Huriez Chu Lille, Lille Hopital Saint Louis, Paris Germany
Universitaetsklinikum Leipzig Aor, Leipzig Universitaetsklinikum Ulm, Ulm Italy
Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola Niguarda Cancer Center Division of Hematology, Milan New Zealand
North Shore Hospital, Auckland Wellington Regional Hospital (Ccdhb), Wellington South Korea
Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi Spain
Hospital de La Santa Creu I Sant Pau, Barcelona Hospital Universitario de Salamanca, Salamanca Hospital Universitario Virgen Del Rocio, Seville Hospital Universitari I Politecnic La Fe, Valencia United Kingdom
Edinburgh Cancer Centre, Edinburgh The Christie Hospital, Greater Manchester